Schrodinger, Inc. (SDGR) stock
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3044% above fair value
$25.66−1.70 (-6.21%)
Close on Nov 17, 2026Market cap $1.92BP/E –Yield –
Schrodinger operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Schrodinger's operating income for the twelve months ending Jun 30, 2026 was -$153.45M. For fiscal 2025 it was -$166.90M. The highest annual figure on record is -$38.72M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$166.90M | – |
| FY2024 | Dec 31, 2024 | -$209.30M | – |
| FY2023 | Dec 31, 2023 | -$177.45M | – |
| FY2022 | Dec 31, 2022 | -$146.82M | – |
| FY2021 | Dec 31, 2021 | -$111.44M | – |
| FY2020 | Dec 31, 2020 | -$60.92M | – |
| FY2019 | Dec 31, 2019 | -$38.72M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$41.55M | – |
| Q1 FY2026 | Mar 31, 2026 | -$48.79M | – |
| Q4 FY2025 | Dec 31, 2025 | -$17.16M | – |
| Q3 FY2025 | Sep 30, 2025 | -$45.95M | – |
| Q2 FY2025 | Jun 30, 2025 | -$52.90M | – |
| Q1 FY2025 | Mar 31, 2025 | -$50.89M | – |
| Q4 FY2024 | Dec 31, 2024 | -$20.71M | – |
| Q3 FY2024 | Sep 30, 2024 | -$68.42M | – |
| Q2 FY2024 | Jun 30, 2024 | -$52.73M | – |
| Q1 FY2024 | Mar 31, 2024 | -$67.43M | – |
| Q4 FY2023 | Dec 31, 2023 | -$29.62M | – |
| Q3 FY2023 | Sep 30, 2023 | -$56.19M | – |
| Q2 FY2023 | Jun 30, 2023 | -$61.13M | – |
| Q1 FY2023 | Mar 31, 2023 | -$30.50M | – |
| Q4 FY2022 | Dec 31, 2022 | -$28.54M | – |
| Q3 FY2022 | Sep 30, 2022 | -$46.16M | – |
| Q2 FY2022 | Jun 30, 2022 | -$43.47M | – |
| Q1 FY2022 | Mar 31, 2022 | -$28.64M | – |
| Q4 FY2021 | Dec 31, 2021 | -$22.52M | – |
| Q3 FY2021 | Sep 30, 2021 | -$34.67M | – |
| Q2 FY2021 | Jun 30, 2021 | -$30.34M | – |
| Q1 FY2021 | Mar 31, 2021 | -$23.91M | – |
| Q4 FY2020 | Dec 31, 2020 | -$16.58M | – |
| Q3 FY2020 | Sep 30, 2020 | -$15.45M | – |
| Q2 FY2020 | Jun 30, 2020 | -$17.09M | – |
| Q1 FY2020 | Mar 31, 2020 | -$11.80M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.85M | – |
| Q3 FY2019 | Sep 30, 2019 | -$11.29M | – |
| Q2 FY2019 | Jun 30, 2019 | -$13.96M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.61M | – |
See a number that looks wrong?